Parent Project Muscular Dystrophy Invests $500,000 in Myosana Therapeutics to Advance Non-Viral Gene Therapy Platform

/PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), today...

Related Keywords

Washington ,District Of Columbia ,United States , ,Instagram ,Myosana Therapeutics Inc ,Research Strategy ,Youtube ,Twitter ,Facebook ,Which Facilitated Crucial Data ,Project Muscular Dystrophy ,Myosana Therapeutics ,Venture Philanthropy ,Parent Project Muscular Dystrophy ,Parent Project Muscular Dystrophy Ppmd ,